Genscript Biotech Corporation
GNNSF | OTC
$4.50
$0.00 (0.00%)
Nov 2, 2026, 10:36 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 173.59M | 131.99M | 1.45B | 1.02B | 1.18B | 629.06M |
Short-Term Investments | 669.41M | 489.2M | 481.65M | 228.89M | 222.53M | 137.46M |
Long-Term Investments | 3.11B | 3.79B | -396.24M | 16.03M | 18.47M | 13.99M |
Other Long-Term Assets | 26.53M | 43.54M | 642.98M | -15.05M | -5.09M | -3.7M |
Receivables | 133.92M | 118.72M | 218.83M | 104.28M | 142.44M | 141.75M |
Inventory | 39.59M | 31.1M | 53.35M | 59.94M | 44.36M | 31.75M |
Other Current Assets | 40.36M | 54.68M | 150.89M | 134.89M | 41.07M | 43.62M |
Total Current Assets | 1.06B | 834.98M | 2.35B | 1.76B | 1.64B | 993.17M |
Property-Plant & Equipment | 623.19M | 595.62M | 750.95M | 624.67M | 486.91M | 379.23M |
Goodwill & Intangibles | 14.62M | 14.37M | 20M | 26.36M | 40.57M | 40.14M |
Total Long-Term Assets | 3.8B | 4.44B | 1.03B | 667.06M | 545.95M | 433.36M |
Total Assets | 4.85B | 5.28B | 3.39B | 2.55B | 2.23B | 1.45B |
Account Payables | 36.78M | 29.84M | 39.96M | 55.76M | 30.18M | 23.38M |
Deferred Revenue | 48.19M | n/a | n/a | -44.79M | -8.03M | -47.23M |
Short-Term Debt | 468.15M | 88.75M | 57.01M | 33.68M | 521K | 44.64M |
Other Current Liabilities | 74.11M | 111.38M | 224.2M | 280.19M | 227.02M | 190.14M |
Total Current Liabilities | 720.08M | 307.34M | 494.81M | 545.98M | 413.31M | 327.91M |
Long-Term Debt | 85.92M | 570.48M | 287.21M | 261.01M | 121.07M | 1.26M |
Other Long-Term Liabilities | 1.3M | 20.1M | 443.44M | 236.02M | 261.19M | -31.26M |
Total Long-Term Liabilities | 156.22M | 647.57M | 848.14M | 567.23M | 432.87M | 1.26M |
Total Liabilities | 876.3M | 954.91M | 1.34B | 1.18B | 846.18M | 631.82M |
Total Debt | 258.84M | 723.74M | 416.99M | 349.8M | 156.45M | 55M |
Book Value | 3.98B | 4.32B | 2.04B | 1.36B | 1.39B | 815.59M |
Book Value Per Share | 1.81 | 1.98 | 0.97 | 0.65 | 0.68 | 0.43 |
Common Stock | 2.18M | 2.14M | 2.12M | 2.11M | 2.1M | 1.95M |
Retained Earnings | 1.8B | 2.36B | -597.73M | -502.25M | -275.4M | -175.01M |
Comprehensive Income | 176.79M | -20.56M | 56.87M | 49.57M | 60.78M | 24.92M |
Shareholders Equity | 3.96B | 4.32B | 1.39B | 1.01B | 1.05B | 901.71M |
Total Investments | 3.78B | 4.28B | 85.41M | 244.92M | 241M | 151.45M |
Add to Watchlist
Select watchlists to add or remove GNNSF